Local anesthetic with opioid analgesic combination

4 marketed 1 in Phase 3

This page covers all Local anesthetic with opioid analgesic combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-gated sodium channels (bupivacaine); mu-opioid receptor (fentanyl), Voltage-gated sodium channels (bupivacaine); mu opioid receptor (fentanyl), Voltage-gated sodium channels (ropivacaine); mu opioid receptor (fentanyl).

Targets

Voltage-gated sodium channels (bupivacaine); mu-opioid receptor (fentanyl) · Voltage-gated sodium channels (bupivacaine); mu opioid receptor (fentanyl) · Voltage-gated sodium channels (ropivacaine); mu opioid receptor (fentanyl) · Voltage-gated sodium channels; mu-opioid receptor · Voltage-gated sodium channels (ropivacaine); mu-opioid receptor (sufentanil)

Marketed (4)

Phase 3 pipeline (1)